Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 1
1934 1
1936 1
1938 1
1941 1
1945 2
1946 10
1947 17
1948 9
1949 6
1950 6
1951 5
1952 6
1953 7
1954 8
1955 5
1956 5
1957 7
1958 6
1959 3
1960 7
1961 2
1962 1
1963 6
1964 8
1965 13
1966 7
1967 4
1968 6
1969 8
1970 3
1971 5
1972 8
1973 8
1974 13
1975 11
1976 20
1977 12
1978 13
1979 22
1980 14
1981 15
1982 16
1983 10
1984 24
1985 19
1986 23
1987 29
1988 35
1989 29
1990 37
1991 43
1992 41
1993 44
1994 47
1995 53
1996 44
1997 71
1998 38
1999 55
2000 44
2001 55
2002 60
2003 51
2004 52
2005 56
2006 61
2007 62
2008 63
2009 68
2010 52
2011 80
2012 89
2013 81
2014 64
2015 61
2016 88
2017 74
2018 82
2019 98
2020 100
2021 127
2022 66
Text availability
Article attribute
Article type
Publication date

Search Results

2,416 results
Results by year
Filters applied: . Clear all
Page 1
Artificial intelligence in radiology.
Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Hosny A, et al. Among authors: schwartz lh. Nat Rev Cancer. 2018 Aug;18(8):500-510. doi: 10.1038/s41568-018-0016-5. Nat Rev Cancer. 2018. PMID: 29777175 Free PMC article. Review.
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litière S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EGE; RECIST working group. Seymour L, et al. Among authors: schwartz lh. Lancet Oncol. 2017 Mar;18(3):e143-e152. doi: 10.1016/S1470-2045(17)30074-8. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28271869 Free PMC article. Review.
Artificial intelligence in cancer imaging: Clinical challenges and applications.
Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, Schwartz LH, Gillies RJ, Huang RY, Aerts HJWL. Bi WL, et al. Among authors: schwartz lh. CA Cancer J Clin. 2019 Mar;69(2):127-157. doi: 10.3322/caac.21552. Epub 2019 Feb 5. CA Cancer J Clin. 2019. PMID: 30720861 Free PMC article. Review.
RECIST 1.1-Update and clarification: From the RECIST committee.
Schwartz LH, Litière S, de Vries E, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, Hayes W, Hodi FS, Hoekstra OS, Huang EP, Lin N, Liu Y, Therasse P, Wolchok JD, Seymour L. Schwartz LH, et al. Eur J Cancer. 2016 Jul;62:132-7. doi: 10.1016/j.ejca.2016.03.081. Epub 2016 May 14. Eur J Cancer. 2016. PMID: 27189322 Free PMC article.
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models.
Kim H, Xu H, George E, Hallberg D, Kumar S, Jagannathan V, Medvedev S, Kinose Y, Devins K, Verma P, Ly K, Wang Y, Greenberg RA, Schwartz L, Johnson N, Scharpf RB, Mills GB, Zhang R, Velculescu VE, Brown EJ, Simpkins F. Kim H, et al. Among authors: schwartz l. Nat Commun. 2020 Jul 24;11(1):3726. doi: 10.1038/s41467-020-17127-2. Nat Commun. 2020. PMID: 32709856 Free PMC article.
The Warburg Effect and the Hallmarks of Cancer.
Schwartz L, Supuran CT, Alfarouk KO. Schwartz L, et al. Anticancer Agents Med Chem. 2017;17(2):164-170. doi: 10.2174/1871520616666161031143301. Anticancer Agents Med Chem. 2017. PMID: 27804847 Review.
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.
Valent P, Akin C, Bonadonna P, Hartmann K, Brockow K, Niedoszytko M, Nedoszytko B, Siebenhaar F, Sperr WR, Oude Elberink JNG, Butterfield JH, Alvarez-Twose I, Sotlar K, Reiter A, Kluin-Nelemans HC, Hermine O, Gotlib J, Broesby-Olsen S, Orfao A, Horny HP, Triggiani M, Arock M, Schwartz LB, Metcalfe DD. Valent P, et al. Among authors: schwartz lb. J Allergy Clin Immunol Pract. 2019 Apr;7(4):1125-1133.e1. doi: 10.1016/j.jaip.2019.01.006. Epub 2019 Feb 5. J Allergy Clin Immunol Pract. 2019. PMID: 30737190 Free PMC article. Review.
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal.
Valent P, Akin C, Hartmann K, Alvarez-Twose I, Brockow K, Hermine O, Niedoszytko M, Schwaab J, Lyons JJ, Carter MC, Elberink HO, Butterfield JH, George TI, Greiner G, Ustun C, Bonadonna P, Sotlar K, Nilsson G, Jawhar M, Siebenhaar F, Broesby-Olsen S, Yavuz S, Zanotti R, Lange M, Nedoszytko B, Hoermann G, Castells M, Radia DH, Muñoz-Gonzalez JI, Sperr WR, Triggiani M, Kluin-Nelemans HC, Galli SJ, Schwartz LB, Reiter A, Orfao A, Gotlib J, Arock M, Horny HP, Metcalfe DD. Valent P, et al. Among authors: schwartz lb. Hemasphere. 2021 Oct 13;5(11):e646. doi: 10.1097/HS9.0000000000000646. eCollection 2021 Nov. Hemasphere. 2021. PMID: 34901755 Free PMC article. Review.
Sorafenib for Advanced and Refractory Desmoid Tumors.
Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK. Gounder MM, et al. Among authors: schwartz lh. N Engl J Med. 2018 Dec 20;379(25):2417-2428. doi: 10.1056/NEJMoa1805052. N Engl J Med. 2018. PMID: 30575484 Free PMC article. Clinical Trial.
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P, Akin C, Nedoszytko B, Bonadonna P, Hartmann K, Niedoszytko M, Brockow K, Siebenhaar F, Triggiani M, Arock M, Romantowski J, Górska A, Schwartz LB, Metcalfe DD. Valent P, et al. Among authors: schwartz lb. Int J Mol Sci. 2020 Nov 27;21(23):9030. doi: 10.3390/ijms21239030. Int J Mol Sci. 2020. PMID: 33261124 Free PMC article. Review.
2,416 results